1. (1) HDCP manufacturers must, in addition to labeling requirements under the Act, label each HDCP with the following:

   1. (a) Batch number;
   2. (b) Name and address of the HDC product manufacturer or wholesaler;
   3. (c) A list of all ingredients, ordered by weight, including direct and indirect additives;
   4. (d) A separate allergen statement, stating common name of allergen, if product contains any of the following ingredients: eggs; fish; milk; tree nuts; peanuts; sesame; shellfish; soy; or wheat;
   5. (e) A QR code that links the viewer to the COA of the applicable product testing results conforming with the THC content methodology set forth in T.C.A. 57-7-102(15). A QR code that does not link to a valid COA, including the product’s batch number, date received, date of testing completion, and method of analysis, as established in T.C.A. § 57-7-107, will be considered invalid and a violation of this rule;
   6. (f) Serving size of the product and the total number of servings per package of the product (applicable only for ingestible HDCPs);
   7. (g) The numerical count, net weight, or net volume of the product per package. Net weight and net volume must be reported in standard and metric measurements.
   8. (h) HDCP packaging and labeling may not contain any statement, illustration, or image that includes false, deceptive, or misleading statements or promotes over-consumption; CANNABINOID PRODUCTS
   9. (i) HDCP packaging and labeling may not contain any statement, illustration, or image that depicts a child or other person under legal age consuming cannabis products;
   10. (j) HDCP packaging and labeling may not contain any seal, flag, crest, coat of arms, or other insignia that could reasonably mislead a person to believe that the cannabis items or package has been endorsed, manufactured, or used by any state, country, county, municipality, or agency;
   11. (k) HDCP packaging may not resemble or mimic the trademarked, characteristic, or product- specialized packaging of any commercially available food product, baked good, snack item, lollipop, chewing gum, candy, or beverage;
   12. (l) HDCPs may not include a statement, artwork, or design that could reasonably mislead a person to believe that the package contains anything other than an HDCP;
   13. (m) HDCPs may not include health claims that are false, misleading, or not supported by competent and reliable scientific evidence. Any permitted health-related information must include the statement: “This product has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease,” unless the product has been evaluated by the Food and Drug Administration and may lawfully make such claims under federal law.
   14. (n) If the label requirements cannot fit on the product, an outer package that contains a scannable QR code linking to the manufacturer’s website that lists the information is acceptable.

2. (2) Warning statements. HDCP manufacturers must include the following warning statement(s), printed in at least eleven (11) point font, easily legible font on the label panel of associated HDCPs, and shall be conspicuous and in distinct contrast (e.g. by typography, layout, color, or embossing) to other information on the package.

   1. (a) For all HDCPs.

      1. 1. “Warning: Keep out of reach of children. Must be 21 or older to possess or consume. May be harmful to those who are pregnant or breastfeeding. May impair ability to drive or operate machinery. This product is not approved by FDA for cure, mitigation, treatment, or prevention of any disease.”
      2. 2. The word “Warning” must be printed in bold font, all capital letters.

   2. (b) Additional warning statement for inhalable HDCPs.

      1. 1. “Warning: Inhalation of cannabis smoke has been associated with lung injury.”
      2. 2. The word “Warning” must be printed in bold font, all capital letters.
      3. 3. A person shall not manufacture or distribute any HDCP labeled as a dietary supplement.

Authority: T.C.A. §§ 57-7-106, 57-7-107, 57-7-110, and 57-7-116. Administrative History: Emergency rules filed December 26, 2025; effective through June 24, 2026. New rules filed March 11, 2026; effective June 9, 2026. CANNABINOID PRODUCTS